A Phase 3, Open-Label, Safety Study of Lofexidine

Trial Profile

A Phase 3, Open-Label, Safety Study of Lofexidine

Completed
Phase of Trial: Phase III

Latest Information Update: 05 May 2017

At a glance

  • Drugs Lofexidine (Primary)
  • Indications Opioid abuse
  • Focus Adverse reactions; Registrational
  • Acronyms NU LEAF
  • Sponsors US WorldMeds
  • Most Recent Events

    • 06 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top